These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10555380)

  • 1. Insulin lispro (Humalog), a novel fast-acting insulin analogue for the treatment of diabetes mellitus: overview of pharmacological and clinical data.
    Hermans MP; Nobels FR; De Leeuw I
    Acta Clin Belg; 1999 Oct; 54(5):233-40. PubMed ID: 10555380
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin lispro (Humalog) in the treatment of diabetes mellitus: overview of belgian clinical data from global studies.
    Bex M; Buysschaert M; De Leeuw I; De Schepper J; Fery F; Hermans MP; Keymeulen B; Lauvaux JP; Letiexhe M; Mathieu C; Nobels FR; Rottiers R; Scheen A; Schmitt H; Van Crombrugge P; Van Gaal L
    Acta Clin Belg; 1999 Oct; 54(5):241-5. PubMed ID: 10555381
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin lispro (Humalog), a novel fast-acting insulin analogue: guidelines for its practical use.
    Nobels FR; Hermans MP; De Leeuw I
    Acta Clin Belg; 1999 Oct; 54(5):246-54. PubMed ID: 10555382
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin lispro: a review of its use in the management of diabetes mellitus.
    Simpson D; McCormack PL; Keating GM; Lyseng-Williamson KA
    Drugs; 2007; 67(3):407-34. PubMed ID: 17335298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin lispro, a new insulin analog.
    Kucera ML; Graham JP
    Pharmacotherapy; 1998; 18(3):526-38. PubMed ID: 9620104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin analogues: new agents for improving glycemic control.
    White JR; Campbell RK; Hirsch I
    Postgrad Med; 1997 Feb; 101(2):58-60, 63-5, 70. PubMed ID: 9046926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review.
    Fordan S; Raskin P
    Vasc Health Risk Manag; 2009; 5(1):225-31. PubMed ID: 19436644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin lispro: a fast-acting insulin analog.
    Noble SL; Johnston E; Walton B
    Am Fam Physician; 1998 Jan; 57(2):279-86, 289-92. PubMed ID: 9456992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog).
    Roper NA; Bilous RW
    Diabet Med; 1998 Dec; 15(12):1063-4. PubMed ID: 9868982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin analogs: structure, properties and therapeutic indications. Part 1: rapid-acting insulin analogs].
    Rosak C
    Internist (Berl); 2001 Nov; 42(11):1523-35. PubMed ID: 11732106
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits of lispro insulin: control of postprandial glucose levels is within reach.
    Bohannon NJ
    Postgrad Med; 1997 Feb; 101(2):73-6, 79-80. PubMed ID: 9046927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin lispro: a useful advance in insulin therapy.
    Heller S
    Expert Opin Pharmacother; 2003 Aug; 4(8):1407-16. PubMed ID: 12877647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Humalog® 200 U/ml KwikPen™].
    Scheen AJ
    Rev Med Liege; 2015 Oct; 70(10):527-31. PubMed ID: 26727843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmaceutical development and clinical experiment of new antidiabetic drugs, premixed preparations of insulin lispro (Humalog Mix 25 and Humalog Mix 50) and intermediate-acting insulin lispro (Humalog N)].
    Awa T; Nakata T; Shigeta H
    Nihon Yakurigaku Zasshi; 2005 Aug; 126(2):143-51. PubMed ID: 16205018
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U-200 Humalog Insulin Now Available in United States.
    Chabanuk AJ
    Home Healthc Now; 2016 Feb; 34(2):102. PubMed ID: 26835809
    [No Abstract]   [Full Text] [Related]  

  • 17. Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Response to Kitzmiller et al.
    Jovanovic L
    Diabetes Care; 1999 May; 22(5):846-8. PubMed ID: 10332693
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic allergic reaction by a human insulin analog.
    Barranco R; Herrero T; Tornero P; Barrio M; Frutos C; Rodríguez A; Malvetti V; Luisa Baeza M
    Allergy; 2003 Jun; 58(6):536-7. PubMed ID: 12757463
    [No Abstract]   [Full Text] [Related]  

  • 19. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
    Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
    Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues.
    Kamal AD; Bain SC
    Expert Opin Drug Saf; 2007 Jan; 6(1):5-7. PubMed ID: 17181446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.